0001801385-24-000009.txt : 20240301 0001801385-24-000009.hdr.sgml : 20240301 20240301201638 ACCESSION NUMBER: 0001801385-24-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240228 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROMANO KATHRYN CENTRAL INDEX KEY: 0001801385 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38210 FILM NUMBER: 24712508 MAIL ADDRESS: STREET 1: C/O KRYSTAL BIOTECH, INC. STREET 2: 2100 WHARTON STREET, SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 FORMER NAME: FORMER CONFORMED NAME: Romano Kathryn DATE OF NAME CHANGE: 20200128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Krystal Biotech, Inc. CENTRAL INDEX KEY: 0001711279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821080209 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: (412) 586-5830 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 4 1 wk-form4_1709342189.xml FORM 4 X0508 4 2024-02-28 0 0001711279 Krystal Biotech, Inc. KRYS 0001801385 ROMANO KATHRYN C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203 0 1 0 0 Chief Accounting Officer 1 Common Stock 2024-02-28 4 M 0 523 63.55 A 13459 D Common Stock 2024-02-28 4 S 0 523 163.134 D 12936 D Common Stock 2024-02-28 4 M 0 744 63.55 A 13680 D Common Stock 2024-02-28 4 S 0 744 164.6031 D 12936 D Common Stock 2024-02-28 4 M 0 130 63.55 A 13066 D Common Stock 2024-02-28 4 S 0 130 165.2197 D 12936 D Common Stock 2024-02-28 4 M 0 100 63.55 A 13036 D Common Stock 2024-02-28 4 S 0 100 166.215 D 12936 D Common Stock 2024-02-28 4 M 0 700 63.55 A 13636 D Common Stock 2024-02-28 4 S 0 700 168.9136 D 12936 D Common Stock 2024-02-28 4 M 0 203 63.55 A 13139 D Common Stock 2024-02-28 4 S 0 203 169.468 D 12936 D Common Stock 2024-02-28 4 M 0 100 63.55 A 13036 D Common Stock 2024-02-28 4 S 0 100 171.45 D 12936 D Common Stock 2024-02-28 4 M 0 637 63.55 A 13573 D Common Stock 2024-02-28 4 S 0 637 162.7254 D 12936 D Common Stock 2024-02-28 4 M 0 786 63.55 A 13722 D Common Stock 2024-02-28 4 S 0 786 163.4937 D 12936 D Common Stock 2024-02-28 4 M 0 1600 63.55 A 14536 D Common Stock 2024-02-28 4 S 0 1600 164.8444 D 12936 D Common Stock 2024-02-28 4 M 0 200 63.55 A 13136 D Common Stock 2024-02-28 4 S 0 200 166.04 D 12936 D Common Stock 2024-02-28 4 M 0 300 63.55 A 13236 D Common Stock 2024-02-28 4 S 0 300 167.85 D 12936 D Common Stock 2024-02-28 4 M 0 1133 63.55 A 14069 D Common Stock 2024-02-28 4 S 0 1133 169.095 D 12936 D Common Stock 2024-02-28 4 M 0 210 63.55 A 13146 D Common Stock 2024-02-28 4 S 0 210 169.751 D 12936 D Common Stock 2024-02-28 4 M 0 134 63.55 A 13070 D Common Stock 2024-02-28 4 S 0 134 171.6554 D 12936 D Stock Option (Right to Buy) 63.55 2024-02-28 2024-02-28 4 M 0 2500 0 D 2032-02-28 Common Stock 2500 35000 D Stock Option (Right to Buy) 63.55 2024-02-28 2024-02-28 4 M 0 5000 0 D 2032-02-28 Common Stock 5000 30000 D The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 2,500 shares with a limit price of $140.00 per share. The transaction was executed in multiple trades ranging from $162.825 to $163.820. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $164.030 to $164.960. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $165.050 to $165.270. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $168.275 to $169.190. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $169.345 to $170.000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on August 29, 2023 and will terminate on June 28, 2024 and contemplates option exercises and sales of 5,000 shares with a limit price of $145.00 per share. The transaction was executed in multiple trades ranging from $162.115 to $163.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $163.120 to $164.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $164.360 to $165.270. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $165.980 to $166.100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $167.540 to $168.010. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $168.680 to $169.500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $169.690 to $169.970. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. The transaction was executed in multiple trades ranging from $171.460 to $172.230. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. 50,000 options were granted that vest in four equal annual installments with the first installment vesting on February 28, 2023. /s/ Kathryn Romano 2024-03-01